Equitable and Ethical Access to Care: The Case of Pre-Hospital Blood Administration
The pre-hospital administration of blood products should be a priority for policy makers and regulatory bodies in Massachusetts.
access to medicine
-
Read more: Equitable and Ethical Access to Care: The Case of Pre-Hospital Blood Administration -
Read more: Book Review: ‘Drugs and the FDA: Safety, Efficacy, and the Public’s Trust’ by Mikkael A. Sekeres Book Review: ‘Drugs and the FDA: Safety, Efficacy, and the Public’s Trust’ by Mikkael A. Sekeres
“Drugs and the FDA” is a must-read for anyone interested in how the FDA became the trusted regulatory agency it is today.
-
Read more: Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic
Activists in the access-to-medicines movement have mobilized to combat the threat of vaccine/therapeutic apartheid during the COVID-19 pandemic.
-
Read more: Drone-Enabled Pharmaceutical Delivery: Navigating Regulatory Turbulence Drone-Enabled Pharmaceutical Delivery: Navigating Regulatory Turbulence
Drone-enabled pharmaceutical delivery offers a number of advantages over its low-tech forebears, not least including patient convenience.
-
Read more: Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS
Join us at yet another webinar with J. Wested at the University of Copenhagen. This time we will debate procedural issues in compulsory licensing with H. Grosse Ruse-Kahn (University of Cambridge) & M. Desai (Eli Lilly). Further information on our webinar series is available at here, here, and below: Procedural Aspects of Compulsory Licensing under Trade-Related Aspects of Intellectual…